CN107441236A - 一种雨生红球藻虾青素保肝护肝产品及其制备方法 - Google Patents
一种雨生红球藻虾青素保肝护肝产品及其制备方法 Download PDFInfo
- Publication number
- CN107441236A CN107441236A CN201710406431.1A CN201710406431A CN107441236A CN 107441236 A CN107441236 A CN 107441236A CN 201710406431 A CN201710406431 A CN 201710406431A CN 107441236 A CN107441236 A CN 107441236A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- haematococcus pluvialis
- parts
- liver protecting
- protecting product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 103
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 102
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 102
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 102
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 102
- 241000168517 Haematococcus lacustris Species 0.000 title claims abstract description 95
- 210000004185 liver Anatomy 0.000 title claims abstract description 64
- 230000002633 protecting effect Effects 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 39
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 39
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 38
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 35
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 35
- 150000004676 glycans Chemical class 0.000 claims abstract description 16
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 16
- 239000005017 polysaccharide Substances 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 239000000725 suspension Substances 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 14
- 239000004006 olive oil Substances 0.000 claims abstract description 11
- 235000008390 olive oil Nutrition 0.000 claims abstract description 11
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 8
- 229940068517 fruit extracts Drugs 0.000 claims description 24
- 239000000686 essence Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229920001285 xanthan gum Polymers 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 9
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 7
- 241000195493 Cryptophyta Species 0.000 claims description 6
- 229920002752 Konjac Polymers 0.000 claims description 6
- 239000001814 pectin Substances 0.000 claims description 6
- 235000010987 pectin Nutrition 0.000 claims description 6
- 229920001277 pectin Polymers 0.000 claims description 6
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 5
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 5
- 229920002581 Glucomannan Polymers 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 239000000252 konjac Substances 0.000 claims description 5
- 235000010485 konjac Nutrition 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- -1 field 7th Substances 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 241000206575 Chondrus crispus Species 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 8
- 230000008520 organization Effects 0.000 abstract description 7
- 208000004930 Fatty Liver Diseases 0.000 abstract description 5
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 5
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 208000010706 fatty liver disease Diseases 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 5
- 238000009825 accumulation Methods 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 abstract description 3
- 108010082126 Alanine transaminase Proteins 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 238000004945 emulsification Methods 0.000 abstract description 2
- 210000005229 liver cell Anatomy 0.000 abstract 1
- 240000008886 Ceratonia siliqua Species 0.000 description 5
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 241000168525 Haematococcus Species 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000207836 Olea <angiosperm> Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001507939 Cormus domestica Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical group CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 150000003400 sorboses Chemical class 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开的是一种雨生红球藻虾青素保肝护肝产品及其制备方法,雨生红球藻虾青素乳化后与多糖悬浮液、枸杞提取物、田七混合,匀质,获得产品原液,将原液进一步处理,获得一种雨生红球藻虾青素保肝护肝产品,将雨生红球藻虾青素、枸杞提取物、田七、山梨糖醇、食用香精混合,压片,获得一种雨生红球藻虾青素保肝护肝产品,将雨生红球藻虾青素、枸杞提取物、田七、橄榄油混合,获得一种雨生红球藻虾青素保肝护肝产品,本发明制备方法简单、无污染、可大批量产;抗氧化、降低胆固醇、降血脂、抗脂肪肝;可以降低血清谷草转氨酶、谷丙转氨酶的活性,降低肝细胞脂肪堆积,有效缓解乙醇对肝脏组织的损伤。
Description
技术领域
本发明涉及一种保肝护肝产品及其制备方法,更具一点说,涉及一种雨生红球藻虾青素保肝护肝产品及其制备方法。
背景技术
雨生红球藻虾青素(astaxanthin),3,3′-二羟基-4,4′-二酮基-β,β′-胡萝卜素,为萜烯类不饱和化合物,分子式为C40H52O4,分子结构中有两个β-紫罗兰酮环,11个共轭双键。它广泛存在于自然界,如大多数甲壳类动物和鲑科鱼类体内,植物的叶、花、果,以及火烈鸟的羽毛中等,特别是雨生红球藻细胞内。
雨生红球藻虾青素,具有抗氧化、保肝护肝等功效,它是世界上最强的天然抗氧化剂之一,能有效清除细胞内的自由基,增强细胞再生能力,维持机体平衡和减少衰老细胞的堆积,由内而外保护细胞和DNA健康,从而保护皮肤健康。它的抗氧化活性超过现有的抗氧化剂。
雨生红球藻虾青素,可以降低血清谷草转氨酶、谷丙转氨酶的活性,降低肝脏组织中丙二醛的含量,升高血清与肝脏组织中超氧化物歧化酶、谷胱甘肽过氧化物酶活性,并降低肛细胞脂肪堆积,有效缓解乙醇对肝脏组织的损伤。实验表明,雨生红球藻虾青素可能通过抗氧化途径改善乙醇性肝损伤。因此,饮酒前口服6-12mg雨生红球藻虾青素有利健康。
枸杞提取物,棕黄色粉末。主要成分是:枸杞多糖(Lycium barbarumpolysaccharides)分子量为22-25kD,由阿拉伯糖、葡萄糖、半乳糖、甘露糖、木糖、鼠李糖6种单糖成分组成。它具有滋补肝肾,保肝及抗脂肪肝,益精明目的作用。
田七,一种名贵药材,是具有独特功能的人参属中的优异品种。具有滋肝补肺,有比较好的降低胆固醇,降低甘油三脂的作用。
发明内容
本发明的目的在于提供具有抗氧化、降低胆固醇、降血脂、抗脂肪肝等技术特点的一种雨生红球藻虾青素保肝护肝产品及其制备方法。
本发明是通过以下技术方案实现:
一种雨生红球藻虾青素保肝护肝产品,包括下述组分混合而成:雨生红球藻虾青素、枸杞提取物、田七、多糖悬浮液。
作为一种优选,按质量份数,所述多糖悬浮液由2-3000份黄原胶,1-2000份刺槐豆胶、1-2000份果胶、1-2000份魔芋胶、1-2000份羧甲基纤维素、1-2000份瓜尔胶、1-2000份卡拉胶,1-2000份微晶纤维素,1-1000份三聚磷酸钠中两种或两种以上与10000-1000000份纯净水混合而成。
作为一种优选,按质量份数,雨生红球藻虾青素1-12份,枸杞提取物10-300份、田七10-200份。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取1-12份雨生红球藻虾青素,进行乳化,获得雨生红球藻虾青素乳化液;
步骤2):按质量份数,称取2-3000份份黄原胶,1-2000份刺槐豆胶、1-2000份果胶、1-2000份魔芋胶、1-2000份羧甲基纤维素、1-2000份瓜尔胶、1-2000份卡拉胶,1-2000份微晶纤维素,1-1000份三聚磷酸钠,选择其中两种或两种以上混合均匀,再加入10000-1000000份纯净水,搅拌均匀,获得多糖悬浮液,所述多糖悬浮液浓度为0.03-0.3%;
步骤3):按质量份数,称取10-300份枸杞提取物,10-200份田七,将其加入到步骤1)获得的雨生红球藻虾青素乳化液中,搅拌,均质,获得一种雨生红球藻虾青素保肝护肝产品的原液;
步骤4):将步骤3)获得的原液进行调味并混匀,均质,分装,灭菌,获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品,包括下述组分混合而成:雨生红球藻虾青素、枸杞提取物、田七、山梨糖醇、食用香精;雨生红球藻虾青素、枸杞提取物、田七、橄榄油。
作为一种优选,按质量份数,雨生红球藻虾青素1-12份,枸杞提取物10-300份,田七10-200份、79-4479份山梨糖醇、0.01-10份食用香精、179-979份橄榄油。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取1-12份雨生红球藻虾青素,10-300份枸杞提取物,10-200份田七,79-4479份山梨糖醇、0.01-10食用香精,混匀,压片,获得一种雨生红球藻虾青素保肝护肝产品;称取1-12份雨生红球藻虾青素,10-300份枸杞提取物,10-200份田七,179-979份橄榄油,混匀,制成胶囊,获得一种雨生红球藻虾青素保肝护肝产品。
有益效果:制备方法简单、无污染、可大批量产;具有抗氧化、降低胆固醇、降血脂、抗脂肪肝保护肝脏的功效;可以降低血清谷草转氨酶、谷丙转氨酶的活性,降低肝脏组织中丙二醛的含量,升高血清与肝脏组织中超氧化物歧化酶、谷胱甘肽过氧化物酶活性,并降低肛细胞脂肪堆积,有效缓解乙醇对肝脏组织的损伤,有利对健康人群和脂肪肝患者有良好的预防和辅助治疗作用,为人们的肝脏健康提供一款有益且优质的产品。
具体实施方式
以下通过具体的实施方式对本发明作进一步的说明,但本发明的实施方式并不受以下实施例的限制。
实施例1一种雨生红球藻虾青素保肝护肝产品,包括下述组分混合而成:1份雨生红球藻虾青素、50份枸杞提取物、50份田七、24份黄原胶、6份瓜尔胶、50份三聚磷酸钠、100000份纯净水;1份雨生红球藻虾青素、50份枸杞提取物、50份田七、698.6份山梨糖醇、0.4份食用香精;1份雨生红球藻虾青素、50份枸杞提取物、50份田七、699份橄榄油。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取1份雨生红球藻虾青素,进行乳化,获得雨生红球藻虾青素乳化液;
步骤2):按质量份数,称取24份黄原胶,6份瓜尔胶、50份三聚磷酸钠混合均匀,再加入100000份纯净水,搅拌均匀,获得多糖悬浮液,所述多糖悬浮液浓度为0.07%;
步骤3):按质量份数,称取50份枸杞提取物、50份田七,将其加入到步骤1)获得的雨生红球藻虾青素乳化液中,搅拌,均质,获得一种雨生红球藻虾青素保肝护肝产品的原液;
步骤4):将步骤3)获得的原液进行调味并混匀,均质,分装,灭菌,获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取1份雨生红球藻虾青素,50份枸杞提取物,50份田七,698.6山梨糖醇、0.4食用香精,混匀,压片,压成糖果,即获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取1份雨生红球藻虾青素,50份枸杞提取物,50份田七,699份橄榄油,混匀,制成胶囊,即获得一种雨生红球藻虾青素保肝护肝产品。
实施例2一种雨生红球藻虾青素保肝护肝产品,包括下述组分混合而成:6份雨生红球藻虾青素、100份枸杞提取物、100份田七、75份黄原胶、8份魔芋胶、17份刺槐豆胶、40份三聚磷酸钠、100000份纯净水;6份雨生红球藻虾青素、100份枸杞提取物、100份田七、693.5份山梨糖醇、0.5份食用香精;6份雨生红球藻虾青素、100份枸杞提取物、100份田七、694份橄榄油。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取6份雨生红球藻虾青素,进行乳化,获得雨生红球藻虾青素乳化液;
步骤2):按质量份数,称取75份黄原胶、8份魔芋胶、17份刺槐豆胶、40份三聚磷酸钠混合均匀,再加入100000份纯净水,搅拌均匀,获得多糖悬浮液,所述多糖悬浮液浓度为0.13%;
步骤3):按质量份数,称取100份枸杞提取物,100份田七,将其加入到步骤1)获得的雨生红球藻虾青素乳化液中,搅拌,均质,获得一种雨生红球藻虾青素保肝护肝产品的原液;
步骤4):将步骤3)获得的原液进行调味并混匀,均质,分装,灭菌,获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取6份雨生红球藻虾青素,100份枸杞提取物,100份田七,693.5山梨糖醇、0.5食用香精,混匀,压片,压成糖果,即获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取6份雨生红球藻虾青素,100份枸杞提取物,100份田七,694份橄榄油,混匀,制成胶囊,即获得一种雨生红球藻虾青素保肝护肝产品。
实施例3一种雨生红球藻虾青素保肝护肝产品,包括下述组分混合而成:12份雨生红球藻虾青素、200份枸杞提取物、150份田七、112份黄原胶、12份果胶、26份槐豆胶、60份三聚磷酸钠、100000份纯净水;12份雨生红球藻虾青素、200份枸杞提取物、150份田七、437.4份山梨糖醇、0.6份食用香精;12份雨生红球藻虾青素、200份枸杞提取物、150份田七、438份橄榄油。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取12份雨生红球藻虾青素,进行乳化,获得雨生红球藻虾青素乳化液;
步骤2):按质量份数,称取112份黄原胶、12份果胶、26份槐豆胶、60份三聚磷酸钠混合均匀,再加入100000份纯净水,搅拌均匀,获得多糖悬浮液,所述多糖悬浮液浓度为0.20%;
步骤3):按质量份数,称取200份枸杞提取物,150份田七,将其加入到步骤1)获得的雨生红球藻虾青素乳化液中,搅拌,均质,获得一种雨生红球藻虾青素保肝护肝产品的原液;
步骤4):将步骤3)获得的原液进行调味并混匀,均质,分装,灭菌,获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取12份雨生红球藻虾青素,200份枸杞提取物,150份田七,437.4份山梨糖醇、0.6份食用香精,混匀,压片,压成糖果,即获得一种雨生红球藻虾青素保肝护肝产品。
一种雨生红球藻虾青素保肝护肝产品的制备方法,该制备方法采用如下步骤:
步骤1):称取12份雨生红球藻虾青素,200份枸杞提取物,150份田七,438份橄榄油,混匀,制成胶囊,即获得一种雨生红球藻虾青素保肝护肝产品。
最后,需要注意的是,本发明不限于以上实施例,还可以有很多变形。本领域的普通技术人员能从本发明公开的内容中直接导出或联想到的所有变形,均应认为是本发明的保护范围。
Claims (7)
1.一种雨生红球藻虾青素保肝护肝产品,其特征在于,包括下述组分混合而成:雨生红球藻虾青素、枸杞提取物、田七、多糖悬浮液。
2.根据权利要求1所述的一种雨生红球藻虾青素保肝护肝产品,其特征在于:按质量份数,所述多糖悬浮液由2-3000份黄原胶,1-2000份刺槐豆胶、1-2000份果胶、1-2000份魔芋胶、1-2000份羧甲基纤维素、1-2000份瓜尔胶、1-2000份卡拉胶,1-2000份微晶纤维素,1-1000份三聚磷酸钠中两种或两种以上与10000-1000000份纯净水混合而成。
3.根据权利要求1所述的一种雨生红球藻虾青素保肝护肝产品,其特征在于:按质量份数,雨生红球藻虾青素1-12份,枸杞提取物10-300份、田七10-200份。
4.一种如权利要求1-3任一项所述的雨生红球藻虾青素保肝护肝产品的制备方法,其特征在于该制备方法采用如下步骤:
步骤1):称取1-12份雨生红球藻虾青素,进行乳化,获得雨生红球藻虾青素乳化液;
步骤2):按质量份数,称取2-3000份份黄原胶,1-2000份刺槐豆胶、1-2000份果胶、1-2000份魔芋胶、1-2000份羧甲基纤维素、1-2000份瓜尔胶、1-2000份卡拉胶,1-2000份微晶纤维素,1-1000份三聚磷酸钠,选择其中两种或两种以上混合均匀,再加入10000-1000000份纯净水,搅拌均匀,获得多糖悬浮液,所述多糖悬浮液浓度为0.03-0.3%;
步骤3):按质量份数,称取10-300份枸杞提取物,10-200份田七,将其加入到步骤1)获得的雨生红球藻虾青素乳化液中,搅拌,均质,获得一种雨生红球藻虾青素保肝护肝产品的原液;
步骤4):将步骤3)获得的原液进行调味并混匀,均质,分装,灭菌,获得一种雨生红球藻虾青素保肝护肝产品。
5.一种雨生红球藻虾青素保肝护肝产品,其特征在于,包括下述组分混合而成:雨生红球藻虾青素、枸杞提取物、田七、山梨糖醇、食用香精;雨生红球藻虾青素、枸杞提取物、田七、橄榄油。
6.根据权利要求5所述的一种雨生红球藻虾青素保肝护肝产品,其特征在于:按质量份数,雨生红球藻虾青素1-12份,枸杞提取物10-300份,田七10-200份、79-4479份山梨糖醇、0.01-10份食用香精、179-979份橄榄油。
7.一种如权利要求5或6所述的雨生红球藻虾青素保肝护肝产品的制备方法,其特征在于该制备方法采用如下步骤:
步骤1):称取1-12份雨生红球藻虾青素,10-300份枸杞提取物,10-200份田七,79-4479份山梨糖醇、0.01-10食用香精,混匀,压片,获得一种雨生红球藻虾青素保肝护肝产品;称取1-12份雨生红球藻虾青素,10-300份枸杞提取物,10-200份田七,179-979份橄榄油,混匀,制成胶囊,获得一种雨生红球藻虾青素保肝护肝产品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710406431.1A CN107441236A (zh) | 2017-06-02 | 2017-06-02 | 一种雨生红球藻虾青素保肝护肝产品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710406431.1A CN107441236A (zh) | 2017-06-02 | 2017-06-02 | 一种雨生红球藻虾青素保肝护肝产品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107441236A true CN107441236A (zh) | 2017-12-08 |
Family
ID=60486496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710406431.1A Pending CN107441236A (zh) | 2017-06-02 | 2017-06-02 | 一种雨生红球藻虾青素保肝护肝产品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107441236A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109512946A (zh) * | 2018-11-06 | 2019-03-26 | 荆楚理工学院 | 一种养肝明目的硒虫草虾青素 |
CN110638046A (zh) * | 2019-11-05 | 2020-01-03 | 杭州鑫伟低碳技术研发有限公司 | 一种雨生红球藻虾青素水溶粉配方产品 |
CN111363658A (zh) * | 2020-03-05 | 2020-07-03 | 何凤霞 | 一种含雨生红球藻提取物(虾青素)的饮品及其制作方法 |
CN111466502A (zh) * | 2020-04-14 | 2020-07-31 | 攀枝花学院 | 虾青素抗疲劳运动饮料及其制备方法 |
CN113170888A (zh) * | 2021-04-27 | 2021-07-27 | 国珍健康科技(北京)有限公司 | 疏肝解郁食品及其制备方法 |
CN113476531A (zh) * | 2021-08-26 | 2021-10-08 | 无限极(中国)有限公司 | 组合物及其在制备保护线粒体的产品中的应用 |
CN116035183A (zh) * | 2023-02-14 | 2023-05-02 | 昆明白鸥微藻技术有限公司 | 一种虾蟹制品抗氧化增色方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104770740A (zh) * | 2015-05-04 | 2015-07-15 | 威海御膳坊生物科技有限公司 | 一种雨生红球藻虾青素复合制剂 |
-
2017
- 2017-06-02 CN CN201710406431.1A patent/CN107441236A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104770740A (zh) * | 2015-05-04 | 2015-07-15 | 威海御膳坊生物科技有限公司 | 一种雨生红球藻虾青素复合制剂 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109512946A (zh) * | 2018-11-06 | 2019-03-26 | 荆楚理工学院 | 一种养肝明目的硒虫草虾青素 |
CN110638046A (zh) * | 2019-11-05 | 2020-01-03 | 杭州鑫伟低碳技术研发有限公司 | 一种雨生红球藻虾青素水溶粉配方产品 |
CN111363658A (zh) * | 2020-03-05 | 2020-07-03 | 何凤霞 | 一种含雨生红球藻提取物(虾青素)的饮品及其制作方法 |
CN111466502A (zh) * | 2020-04-14 | 2020-07-31 | 攀枝花学院 | 虾青素抗疲劳运动饮料及其制备方法 |
CN113170888A (zh) * | 2021-04-27 | 2021-07-27 | 国珍健康科技(北京)有限公司 | 疏肝解郁食品及其制备方法 |
CN113476531A (zh) * | 2021-08-26 | 2021-10-08 | 无限极(中国)有限公司 | 组合物及其在制备保护线粒体的产品中的应用 |
US11779625B2 (en) | 2021-08-26 | 2023-10-10 | Infinitus (China) Company Ltd. | Composition and application thereof in preparing product for protecting mitochondria |
CN116035183A (zh) * | 2023-02-14 | 2023-05-02 | 昆明白鸥微藻技术有限公司 | 一种虾蟹制品抗氧化增色方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107441236A (zh) | 一种雨生红球藻虾青素保肝护肝产品及其制备方法 | |
CN104351601A (zh) | 黑枸杞果冻及其制备方法 | |
CN105434319B (zh) | 一种基于红发夫酵母原料的化妆品及其制备方法 | |
JP2006306804A (ja) | シワ形成抑制剤 | |
CN102805184A (zh) | 一种玫瑰补血棒棒糖 | |
CN104054847A (zh) | 一种强身健体滋补花生油及其制备方法 | |
CN106550970A (zh) | 一种苦荞蛋糕 | |
CN105106049B (zh) | 一种用于眼部护理的组合物及制备方法 | |
CN104026263A (zh) | 一种抗氧化抗衰老保健芝麻油及其制备方法 | |
CN103462026B (zh) | 一种质量稳定的澳洲坚果油胶囊及其制备方法 | |
CN104248036A (zh) | 一种黑果枸杞原花青素泡腾片及其生产方法 | |
CN109997996A (zh) | 一种防老抗衰的功能性饮品及其制备方法 | |
CN103750094A (zh) | 雄蜂蛹保健膏及其制备方法 | |
CN107320382B (zh) | 一种含有银耳提取物的组合物及在个人护理品中的应用 | |
KR101058421B1 (ko) | 한방 건강 보조 식품 및 그의 제조방법 | |
JP2006298887A (ja) | 活性酸素除去剤、肌の弾力保持剤、抗酸化作用補助剤 | |
CN104783031B (zh) | 一种护肝护脑组合物 | |
CN107028181A (zh) | 一种鱼腥草金银花膏及其制作方法 | |
CN103734704A (zh) | 具有清火水果粉的功能食品及其制备方法 | |
KR102043433B1 (ko) | 홍삼 추출물의 제조 방법 | |
CN102813103A (zh) | 一种益智仁果冻及其制备方法 | |
CN106912920A (zh) | 一种含有桑叶提取物的组合物及其用途 | |
CN109122856A (zh) | 一种护肝醒酒中药组合物 | |
CN108740973A (zh) | 一种纯天然玫瑰酱及其制备方法 | |
KR102283497B1 (ko) | 항산화능이 우수한 스틱형 젤리 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171208 |